Updates in MASLD

Overview

Fatty liver disease affects millions and the science is evolving rapidly. Join us for a high-yield session covering the latest nomenclature updates, risk stratification tools, and breakthrough therapeutic options. Walk away with actionable strategies to identify at-risk patients earlier, assess fibrosis with confidence, and stay ahead of the curve in managing steatotic liver disease.

Click here to answer audience response questions, access downloadable slides, and ask questions to the presenter.

Learning Objectives

• As a result of participating in this activity, learners will be able to identify risk factors for development of steatotic liver disease
• As a result of participating in this activity, learners will be able to apply non-invasive testing strategies to screen for steatotic liver disease and chronic liver disease
• As a result of participating in this activity, learners will be able to apply interventions to treat steatotic liver disease and prevent disease progression